$AMBQ

ZHANG KER sold $634K of AMBQ

ZHANG KER sold 10,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $63.44 ($63.39–$63.95, $0.63M total) across 2 trades on 2026-09-11.

Original reporting
SEC EDGAR · ZHANG KER
Published Sep 15, 2026, 10:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 11:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMBQ
Neutral
high confidence
Mentioned
$AMBQ
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQNeutralLow
01

Why it matters

The disclosed sale is modest and does not indicate a material shift in control or confidence.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential upcoming product launches or financing needs not disclosed.

Relevance 5/10Novelty 4/10Timing: filed Sep 15, 2026

Background

Form 4 filings disclose insider transactions; they are primary sources for insider activity.

Company-level read

Ticker impact

$AMBQNeutralHigh confidence
Context

Director Zhang Ker sold 10,000 shares for $634,361 via a Form 4 filing on Sep 15, 2026.

Expected impact

minimal impact; price likely unchanged

Evidence & confidence

Sale size (~$0.63M) is small relative to market cap; no 10b5‑1 plan, so likely personal liquidity need.

Market effects

None; Ambiq operates in low‑volume IoT semiconductor niche.

No regional effect.

Limited to investors tracking insider activity.

Counterpoint

If insider selling signals concerns, a contrarian could short, but evidence is weak.

Key entities

  • Ambiq Micro, Inc.

    US-listed semiconductor company (ticker AMBQ).

  • Zhang Ker

    Director of Ambiq Micro, reporting the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.